Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation
Science Translational Medicine · 17.06.2026 · 18 (854)
DOI: 10.1126/scitranslmed.aee6850 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Science Translational Medicine, erschienen am 17.06.2026. Verfasst von Thomas Wekerle und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplantation, Department of General Surgery, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Bone Marrow Transplantation, Chimerism, Kidney Transplantation, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Vienna Science and Technology Fund.
Abstract (Originalsprache)
Cotransplantation of donor bone marrow (BM) has yielded a therapeutic benefit in clinical trials of kidney transplantation by inducing chimerism-based tolerance, but this was dependent on unfavorable recipient irradiation. Additional regulatory T (T reg ) cell administration can overcome the need for myelosuppression, but this has been demonstrated only in mice so far. Here, we conducted a controlled, phase 1/2a trial of combined BM and T reg cell therapy in HLA-mismatched living-donor kidney transplantation (NCT03867617). Six patients received polyclonal recipient T reg cells and donor BM cells (BMCs) immediately posttransplant. Immunosuppression consisted of thymoglobulin, belatacept, sirolimus, steroids, and short-course tocilizumab. The control group received no T reg cells, BMCs, or tocilizumab. Total leukocyte donor chimerism was detected across all patients in the study group posttransplantation. This was not observed in any patient belonging to the control group, consequently meeting the primary end point of higher chimerism levels in the study versus control groups ( P = 0.001). Chimerism was observed across multiple lineages, with up to 4% in T cells. For three patients in the study group, immunosuppression could be minimized to belatacept monotherapy. Antidonor reactivity was decreased in in vitro T cell proliferation assays, suggesting specific downmodulation of the antidonor T cell response. In addition, expansion of antidonor T cell clones was shown by T cell receptor sequencing analysis to be dampened in the study versus control groups. This trial serves as a proof of concept for a combination cell therapy that induces chimerism-based immunomodulation in kidney transplantation without the need for irradiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Transplantation, Department of General Surgery, Medical University of Vienna, 1090 Vienna, Austria.
- Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
- Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, 1090 Vienna, Austria.
- Institute of Clinical Biometrics, Center for Medical Data Science, Informatics, and Intelligent Systems, Medical University of Vienna, 1090 Vienna, Austria.
- Clinical Trials Coordination Centre, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Thomas Wekerle, Moritz Muckenhuber, Andreas Heinzel, Ana F David, Verena Kainz, Karin Hu, Konstantinos Mengrelis, Roman Reindl-Schwaighofer, Bruno Watschinger, Georg Györi, Andreas Salat, Marlena Muhm, Nina Worel, Heinz Regele, Philip F Halloran, Matthias Edinger, Rainer Oberbauer
Förderung
- Vienna Science and Technology Fund
Zitieren
APA
Wekerle, T., Muckenhuber, M., Heinzel, A., Weijler, A. M., David, A. F., Kainz, V., Hu, K., Mucha, J., Mengrelis, K., Reindl-Schwaighofer, R., Böhmig, G. A., Watschinger, B., Györi, G., Soliman, T., Salat, A., Schwarz, C., Muhm, M., Heinze, G., Wolzt, M., …, & Oberbauer, R. (2026). Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation. Science Translational Medicine, 18(854). https://doi.org/10.1126/scitranslmed.aee6850
Vancouver
Wekerle T, Muckenhuber M, Heinzel A, Weijler AM, David AF, Kainz V, et al. Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation. Science Translational Medicine. 2026;18(854). doi:10.1126/scitranslmed.aee6850
BibTeX
@article{Wekerle2026,
author = {Wekerle, Thomas and Muckenhuber, Moritz and Heinzel, Andreas and Weijler, Anna Marianne and David, Ana F and Kainz, Verena and Hu, Karin and Mucha, Jasmin and Mengrelis, Konstantinos and Reindl-Schwaighofer, Roman and Böhmig, Georg A and Watschinger, Bruno and Györi, Georg and Soliman, Thomas and Salat, Andreas and Schwarz, Christoph and Muhm, Marlena and Heinze, Georg and Wolzt, Michael and Worel, Nina and Fortschegger, Michaela and Lion, Thomas and Regele, Heinz and Berlakovich, Gabriela and Halloran, Philip F and Edinger, Matthias and Oberbauer, Rainer},
title = {Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {854},
doi = {10.1126/scitranslmed.aee6850}
}
EUVIMED